Literature DB >> 22981705

Fingerprinting of the TLR4-induced acute inflammatory response.

Markus Bosmann1, Norman F Russkamp, Peter A Ward.   

Abstract

Intensive scientific efforts in the past decades have helped shed light into the pathogenesis of endotoxin-induced inflammation. We have used multiplexing bead-based assays to characterize the responses in two models of in vivo LPS challenge. C57BL/6 mice were either injected intraperitoneally (endotoxemia) or intratracheally (acute lung injury; ALI) with lipopolysaccharide (LPS). The time courses (1h-24h) of the following 20 inflammatory mediators in plasma or broncho-alveolar lavages were simultaneously analyzed: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-12(p40), IL-13, Eotaxin (CCL11), G-CSF, GM-CSF, IFN-γ, KC (CXCL1), MCP-1 (CCL2), MIP-1α (CCL3), MIP-1β (CCL4), RANTES (CCL5) and TNF-α. While significant inductions of all mediators were found, substantial differences in their absolute concentrations, time points of maximal concentrations and clearances were observed. There were also notable variations in the patterns of several cytokines/chemokines when samples from endotoxemia and LPS-ALI were compared. These data may be helpful in defining analytic strategies including selection of optimal time points for studying the host immune response to endotoxin.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981705      PMCID: PMC3518574          DOI: 10.1016/j.yexmp.2012.08.006

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  22 in total

Review 1.  Innate immune sensing and its roots: the story of endotoxin.

Authors:  Bruce Beutler; Ernst Th Rietschel
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

Review 2.  Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned.

Authors:  K Reinhart; W Karzai
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Robert Koch: the story of his discoveries in tuberculosis.

Authors:  A Sakula
Journal:  Ir J Med Sci       Date:  1985-05       Impact factor: 1.568

4.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

5.  Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages.

Authors:  Markus Bosmann; Mikel D Haggadone; Mark R Hemmila; Firas S Zetoune; J Vidya Sarma; Peter A Ward
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

6.  The cardiovascular response of normal humans to the administration of endotoxin.

Authors:  A F Suffredini; R E Fromm; M M Parker; M Brenner; J A Kovacs; R A Wesley; J E Parrillo
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

7.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

8.  Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

Authors:  C J Fisher; J M Agosti; S M Opal; S F Lowry; R A Balk; J C Sadoff; E Abraham; R M Schein; E Benjamin
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

9.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

Authors:  E Abraham; R Wunderink; H Silverman; T M Perl; S Nasraway; H Levy; R Bone; R P Wenzel; R Balk; R Allred
Journal:  JAMA       Date:  1995 Mar 22-29       Impact factor: 56.272

10.  Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.

Authors:  P S Tobias; K Soldau; R J Ulevitch
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

View more
  12 in total

1.  The pituitary gland prevents shock-associated death by controlling multiple inflammatory mediators.

Authors:  Arjun Sharma; Sebastian Steven; Markus Bosmann
Journal:  Biochem Biophys Res Commun       Date:  2018-12-20       Impact factor: 3.575

2.  CRF-amplified neuronal TLR4/MCP-1 signaling regulates alcohol self-administration.

Authors:  Harry L June; Juan Liu; Kaitlin T Warnock; Kimberly A Bell; Irina Balan; Dominique Bollino; Adam Puche; Laure Aurelian
Journal:  Neuropsychopharmacology       Date:  2015-01-08       Impact factor: 7.853

3.  Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.

Authors:  Keiko Hirose; Song-Zhe Li; Kevin K Ohlemiller; Richard M Ransohoff
Journal:  J Assoc Res Otolaryngol       Date:  2014-05-21

4.  Enhanced resolution of experimental ARDS through IL-4-mediated lung macrophage reprogramming.

Authors:  F R D'Alessio; J M Craig; B D Singer; D C Files; J R Mock; B T Garibaldi; J Fallica; A Tripathi; P Mandke; J H Gans; N Limjunyawong; V K Sidhaye; N M Heller; W Mitzner; L S King; N R Aggarwal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-19       Impact factor: 5.464

5.  LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model.

Authors:  Salvatore Chirumbolo; Guido Franceschetti; Elena Zoico; Clara Bambace; Luciano Cominacini; Mauro Zamboni
Journal:  Inflamm Res       Date:  2014-02-14       Impact factor: 4.575

6.  CD11c+ alveolar macrophages are a source of IL-23 during lipopolysaccharide-induced acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Norman F Russkamp; Robert Ruemmler; Firas S Zetoune; J Vidya Sarma; Peter A Ward
Journal:  Shock       Date:  2013-05       Impact factor: 3.454

7.  Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity.

Authors:  Ja-Won Koo; Lourdes Quintanilla-Dieck; Meiyan Jiang; Jianping Liu; Zachary D Urdang; Jordan J Allensworth; Campbell P Cross; Hongzhe Li; Peter S Steyger
Journal:  Sci Transl Med       Date:  2015-07-29       Impact factor: 17.956

8.  Inhibition of the phosphoinositide 3-kinase pathway decreases innate resistance to lipopolysaccharide toxicity in TLR4 deficient mice.

Authors:  Johnson Chia-Shen Yang; Shao-Chun Wu; Cheng-Shyuan Rau; Tsu-Hsiang Lu; Yi-Chan Wu; Yi-Chun Chen; Ming-Wei Lin; Siou-Ling Tzeng; Chia-Jung Wu; Ching-Hua Hsieh
Journal:  J Biomed Sci       Date:  2014-03-11       Impact factor: 8.410

9.  Effects of atorvastatin combined with low-molecular-weight heparin on plasma inflammatory cytokine level and pulmonary pathophysiology of rats with sepsis.

Authors:  Fei Jing; Ming Li; Hongsheng Ren; Jitian Zhang; Qingchun Yao; Yufeng Chu; Chunting Wang
Journal:  Exp Ther Med       Date:  2016-05-20       Impact factor: 2.447

10.  Penehyclidine hydrochloride inhibits TLR4 signaling and inflammation, and attenuates blunt chest trauma and hemorrhagic shock-induced acute lung injury in rats.

Authors:  Xiao-Jing Wu; Hui-Min Liu; Xue-Min Song; Bo Zhao; Yan Leng; E-You Wang; Li-Ying Zhan; Qing-Tao Meng; Zhong-Yuan Xia
Journal:  Mol Med Rep       Date:  2018-02-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.